2020 annual financial data
X4 Pharmaceuticals 2020 Operating margin
X4 Pharmaceuticals 2020 operating margin with verified reported values.
Direct answer
Operating margin was -1,995.8%.
Operating income was -59,874,000 USD and net income was -62,131,000 USD.
Operating cash flow was -58,818,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -59,874,000 USD
- Net income
- -62,131,000 USD
- Operating cash flow
- -58,818,000 USD